With the use of tracers that specifically bind to the dopamine transporter (DAT) or dopamine receptors, radionuclide imaging evaluates the integrity of the dopamine system in a patient and helps physicians rule out the possibility of other diseases with symptoms similar to PD [3, 5, 9]. The gene discussed is SLC6A3; the disease is Parkinson disease.